LP135650-2
Rivaroxaban
Active
Description
Rivaroxaban is an oral anticoagulant, marketed as Xarelto. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8-12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Rivaroxaban
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2011-09-30
- Construct for LOINC Short Name
- Rivaroxaban
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP135650-2 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP135650-2
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 利伐沙班 Synonyms: 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺; |
es-ES | Spanish (Spain) | Rivaroxaban |
it-IT | Italian (Italy) | Rivaroxaban |
tr-TR | Turkish (Turkey) | Rivaroksaban |
ru-RU | Russian (Russian Federation) | Ривароксабан |
nl-NL | Dutch (Netherlands) | rivaroxaban |
fr-CA | French (Canada) | Rivaroxaban |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright